Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU BSE risk material ban two-year exemption proposed by European Commission.

This article was originally published in The Tan Sheet

Executive Summary

EU BSE RISK MATERIAL PROPOSAL WOULD ALLOW TWO-YEAR EXEMPTION for "medicinal products" already on the market to eliminate use of "specified risk materials" for transmissible spongiform encephalopathies (including bovine SEs, often called "mad cow" disease). "For medicinal products for which few or no satisfactory therapeutic alternatives exist, a member state may allow the use of SRM until an alternative is developed, but at the latest until Dec. 31, 1999," the European Union said Dec. 3. Use of SRM in new products will be banned in the EU beginning Jan. 1 under a July European Commission decision.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087844

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel